Previous studies have suggested that endogenous protease inhibitors may participate in the mucosal host defense. Antileukoprotease (ALP) is an important protease inhibitor found on various mucosal surfaces, including those of the respiratory and genital tracts. This study reports on the antimicrobial activity of recombinant (r) ALP toward the human fungal pathogens Aspergillus fumigatus and Candida albicans. rALP expressed pronounced fungicidal activity toward metabolically active A. fumigatus conidia and C. albicans yeast cells; however, metabolically quiescent A. fumigatus conidia were totally resistant. In contrast with the protease inhibitory activity of rALP, the fungicidal activity was localized primarily in the NH 2 -terminal domain. On a molar base, the fungicidal activity of rALP was comparable with that of human defensins and lysozyme. In addition, rALP caused inhibition of C. albicans yeast cell growth. By exhibiting antifungal activity, ALP may play an important role in the innate mucosal defense against human pathogenic fungi.
The factors that constitute the mucosal host defense against recently the bactericidal activity of recombinant (r) ALP was demonstrated [19] . In the present study, the fungistatic and microorganisms have been studied widely over the past decades. In addition to the various phagocyte granule -associated fungicidal activities of rALP toward the human pathogens Aspergillus fumigatus and Candida albicans are investigated. proteins and peptides, including defensins, lysozyme, lactoferrin, and azurocidin (reviewed in [1]), and the neutrophil cytoplasmic -associated protein calprotectin [2] , protease inhibitors Material and Methods also may play a role in the mucosal defense in different ways.
Protease inhibitors may inhibit protease-mediated degradation
Fungal isolates. The A. fumigatus isolate used in this study of opsonins or receptors involved in phagocytosis [3, 4] or may was originally obtained from a patient with pulmonary aspergilsuppress airway inflammation [5] . However, some studies have loma. A. fumigatus was maintained on malt extract agar (Merck, suggested that protease inhibitors may act as potent antibacteDarmstadt, Germany) at 37ЊC. C. albicans was isolated from the rial agents as well [6, 7] .
blood of a patient with candidiasis and was a gift of H. G. de Antileukoprotease (ALP), also known as secretory leukoproVries-Hospers (Department of Medical Microbiology, Groningen tease inhibitor, is widely distributed [8 -13] and is a major University Hospital, Netherlands). The C. albicans isolate was maintained on Sabouraud agar (Merck) at 30ЊC. Conidia from the protease inhibitor of the mucous secretions of the respiratory test organisms were counted in a hematocytometer and adjusted and genital tracts [14, 15] . ALP is an 11.7-kDa cationic nonglyto desired concentrations. cosylated protein composed of two highly homologous doAntimicrobial (poly)peptides. rALP was produced in Eschemains. In the human lung, ALP is produced locally in the richia coli and purified as described [20, 21] . The rALP preparation submucosal glands and lining epithelium of the bronchi; since was characterized by N-terminal amino acid sequencing, quantita-ALP is a potent inhibitor of endogenous serine proteinase activtive amino acid analysis, SDS-PAGE, and reverse-phase highity, it is suggested that ALP may play a role in maintaining performance liquid chromatography (HPLC). Separated NH 2 -and the proteinase-antiproteinase balance in the lung [16, 17] . The COOH-terminal domains were obtained by partial acid hydrolysis ALP molecule shows sequence homology with an antimicrobial or rALP as described [19, 22] . The isolated domains were characpeptide isolated from equine neutrophils (eNAP-2) [18] , and terized by SDS-PAGE, acid urea PAGE, assessment of the elastase inhibitory activity [19] , and reverse-phase HPLC. N-terminal amino acid sequencing and amino acid composition analysis further confirmed the identity of the NH 2 -terminal (residues Ser-1 to rALP and the rALP domains were dialyzed for 24 h at 4ЊC in C. albicans samples were incubated with rALP for various time periods to assess survival of the remaining organisms over time. 0.01% acidic acid, using dialysis tubes with a 6-to 8-kDa (rALP) or 3.5 kDa (rALP domains) molecular cutoff (Spectra/Por; Spec-
The fungicidal activity was measured as the reduction of inoculum cfu and calculated by the formula [(N control 0 N exp )/N control ] 1 100, trum Medical Industries, Houston) and subsequently stored at 020ЊC. Before and after dialysis, the protein concentration was in which N exp and N control represent the number of cfu obtained after incubation in the presence (N exp ) or absence (N control ) of the determined by the method of Lowry et al. [23] , using bovine serum albumin as a standard, and the results were used to calculate the antimicrobial (poly)peptides.
In vivo, fungal growth may be limited by several factors, such dilution caused by the dialysis procedure. This information was used in combination with the UV spectrometry findings to calculate as nutrient limitations, the concerted actions of fungicidal proteins (e.g., lysozyme) and phagocytic cells (e.g., macrophages), or subthe concentrations of rALP and its domains after dialysis. Furthermore, the rALP concentration was confirmed using a secretory optimal growth temperatures. Since temperatures for growth of A. fumigatus are optimal between 37 and 39ЊC, we studied the effect leukoprotease inhibitor (SLPI) immunoassay (R&D Systems, Minneapolis) and an ELISA for quantification of rALP described by of suboptimal temperatures on the fungicidal activity of rALP by incubating A. fumigatus conidia with rALP at 37ЊC for 2.5 h, Kramps et al. [8] , both recognizing natural and E. coli-expressed recombinant SLPI (and ALP).
followed by incubation of the agar plates at a lower temperature (33ЊC) overnight. Results were compared with control plates incu-A mixture of the human neutrophil defensins HNP-1, HNP-2, and HNP-3 (HNP1-3) was prepared from purulent sputum of bated at 37ЊC. Quantification of fungistatic activity towards C. albicans yeast patients with chronic bronchitis and was characterized as described [19, 24] To obtain single cell suspensions, fungal conidia were placed in cell density was evaluated at 37ЊC for 21 h by reading the absorbance at 630 nm every 10 min with a computerized plate reader 10 mL of sterile distilled water (Ç1.10 8 conidia/mL) containing 0.5% (vol/vol) Tween 20 (Merck) and shaken vigorously for at (Thermomax; Sopar-biochem, Nieuwegein, Netherlands). From the sigmoidal growth curves, the maximum rate of increase of cell least 2 h at room temperature. Two different types of conidia were prepared. The dormant (metabolically quiescent) type of conidia density (V max ) and the lag time before V max was reached (T lag ) were calculated. The fungistatic activity is defined as the increase was prepared by diluting the freshly prepared conidia suspensions in liquid Sabouraud medium (Merck) containing 50 mg/mL gentain T lag (DT lag ) compared with the T lag of control samples.
Statistics. All data are presented as mean { SE. Comparisons micin sulfate (SG medium; Centrafarm Services, Etten-Leur, Netherlands) to 4.10 6 -7.10 6 conidia/mL. The swollen (metabolically were made using the 2-tailed Student's t test. Differences were considered significant if P õ .05. Values are from four independent active) type of conidia was prepared by incubating the dormant type for 19 h at 25ЊC in SG medium (under stationary conditions) experiments unless indicated otherwise. The 50% fungicidal concentration (FC 50 ) was calculated from the linear regression of the followed by an additional incubation for 1-2 h at 37ЊC. By then, microscopic observations revealed cells that had approximately dose-response curves. doubled in size (became ''swollen'') compared with the dormant type. Effect of incubation temperature on fungicidal activity (pH 7.4) were exposed to increasing concentrations of rALP for 2.5 of recombinant (r) ALP toward Aspergillus fumigatus swollen conidia. h and the no. of cfu was evaluated after overnight incubations at 33ЊC
Results

Yeast
A. fumigatus swollen conidia in 10 mM phosphate buffer (pH 7.4) on YM agar. Shown are results found with swollen type (l) and were exposed to rALP (2 or 15 mM) for 2.5 h, followed by subculturdormant type (᭺) of A. fumigatus conidia. Comparisons were made ing on YM agar overnight at 37 or 33ЊC. Comparisons were made using 2-tailed Student's t test. * Statistically significant fungicidal using 2-tailed Student's t test. * Statistically significant fungicidal activity.
activity.
tively). At low concentrations (£0.5 mM), only lysozyme was increased with 15 mM rALP at 33ЊC compared with 37ЊC fungicidal; the fungicidal activity of lysozyme reached statisti-(85.1% { 2.8% and 77.3% { 4.2%, respectively; P õ .04; n cal significance at 0.5 mM (25.9% { 4.9%; P õ .02). At higher Å 5; figure 2 ). No such difference was found with a lower concentrations, lysozyme tended to express a lower fungicidal rALP concentration (2 mM rALP; P ú .3; n Å 5; figure 2). activity (55.8% { 6.9% and 50.8% { 7.2% at 5 and 10 mM, On the basis of these findings, the overnight incubations of respectively) compared with rALP and HNP1 -3 tested at the A. fumigatus spread on agar plates were done at 33ЊC in all same concentrations; however, these differences were not staexperiments. tistically significant (P ú .06). In comparing the FC 50 values
It is difficult to completely rule out the contribution of spore from these experiments, those of rALP (FC 50 
clumping in our observations on the fungicidal activity of and HNP1 -3 (FC 50 Å 6.0 { 0.4 mM) tended to be higher than rALP. However, we have done control experiments in which that of lysozyme (FC 50 Å 4.9 { 2.1 mM), although differences we prepared swollen A. fumigatus conidia suspensions at high were not statistically significant (P ú .4).
concentrations (5 1 10 6 ) and monitored the effect of addition Figure 2 shows the results of a lower temperature for overof rALP (30 mM) for 2.5 h at 37ЊC. The number and sizes of night incubation of the agar plates on the fungicidal activity of the spore clumps involved were evaluated by light microscopy. rALP toward A. fumigatus. Fungicidal activity was significantly Although spore clumping was significant with A. fumigatus (Ç25%) under these conditions, there tended to be a decrease in spore clumping in the 30 mM rALP -treated samples (mean, Comparisons were made using 2-tailed Student's t test. * Statistically (pH 7.4) were exposed to rALP or increasing concentrations of rALP significant fungicidal activity. domains for 2.5 h, and no. of cfu was evaluated after overnight incubations at 33ЊC on YM agar. Comparisons were made using 2-tailed Student's t test. * Statistically significant fungicidal activity.
varied incubation periods on the fungicidal activity of 10 mM rALP toward C. albicans pseudoconidia. The fungicidal activdomain was 9.1 { 2.9 mM; FC 50 for the COOH-terminal doity was time-dependent, reaching 92.7% after 10 h. With longer main could not be calculated due to low fungicidal activity of incubation periods (up to 24 h), the fungicidal activity reached this domain. With the protein concentrations tested, the fungi-98.2%. However, when the assays were performed with incidal activity was statistically significant for the NH 2 -terminal creasing ionic strength of the buffer solutions, rALP lost its domain at 5 mM (29.4% { 10.9%; P õ .04) and for the COOHfungicidal activity toward C. albicans more quickly than did terminal domain at 15 mM (19.6% { 3.6%; P õ .002). Comhuman defensins and lysozyme (figure 6). Using YM agar pared with the fungicidal activity of the intact rALP molecule plates without gentamicin sulfate, Sabouraud agar, or malt exon a molar base, however, that of the NH 2 -terminal domain tract agar plates for the quantification of cfu, comparable results was lower. In one experiment, we compared the fungicidal activity of the individual domains with a combination of both domains and intact rALP (all tested at 15 mM) and found that the fungicidal activity using a combination of both domains (63.1%) approximated the sum of the fungicidal activities that were found with the individual domains (NH 2 domain, 45.0%; COOH domain, 11.9%). However, the fungicidal activity found with the combination of the domains was lower compared with that found with the intact rALP molecule (71.4%, not shown). Figure 4 shows the dose-response curve for the fungicidal activity of rALP toward C. albicans cells. The fungicidal activity was dose-dependent, reaching statistical significance at 1 mM rALP (9.7% { 1.2%; P õ .005). At 15 mM rALP, the fungicidal activity was 59.9% { 4.6%. The FC 50 calculated from these experiments was 10.0 { 1.5 mM.
Fungicidal activity of rALP toward C. albicans yeast cells.
In some experiments, we tested the fungicidal activity of 
Discussion
This report describes the fungicidal and fungistatic activity of rALP toward A. fumigatus and C. albicans. ALP is not glycosylated; therefore, rALP that is synthesized in E. coli is identical to ALP in terms of structure and function [13, 25] . The fungicidal activity of rALP was dose-dependent and comparable to that of human defensins and human lysozyme. The fungicidal activity of rALP was statistically significant with an rALP concentration ú1 mM (C. albicans) or 2 mM (A. fumigatus), although the antimicrobial activity of rALP, like that of other cationic antimicrobial polypeptides [1, 26] , is limited to The concentration at which ALP displays antifungal activity in vitro (ú2 mM) appears to be relevant to the in vivo situation in the lung [8, 28, 29] , since the ALP concentration in the were obtained, indicating that the decrease in cfu count following the incubation with rALP was not due to substrate inhibition epithelial lining fluid of the central airways was estimated to be 8.7 mM [30]. However, one might argue that, at the site of phenomena. Longer incubation periods (ú24 h) of the YM agar plates did not result in a substantial increase in the residual ALP production, serous cells in the submucosal glands and Clara and goblet cells of the bronchiolar and bronchial lining cfu, indicating that the effect was, in fact, fungicidal and not merely fungistatic.
epithelium [31] , the local concentration may be even higher. Therefore, in the lung, ALP may contribute to host defense Fungistatic activity of rALP toward C. albicans yeast cells. Within the dose range of rALP used in this study, the fungicidal against infection by providing the epithelial cells from the central airways with a protective antimicrobial shield. Because activity toward C. albicans (and A. fumigatus) never reached 100%. The residual colonies in the rALP-treated C. albicans of its presence at other mucosal surfaces, including the genital tract [14, 15] , this role is likely not to be restricted to the lung. samples, however, were markedly smaller compared with those of the untreated samples. Since this most likely reflects a proHowever, the contribution of ALP to antimicrobial defense relative to that of other endogenous epithelial antibiotics recess of cell-growth inhibition following the treatment with rALP, we initially tried to quantify growth inhibition by meamains to be determined. suring the maximum rates of increase of cell density of C. albicans (V max ) in GS medium in the presence of various concentrations of rALP. However, when the V max readings were [3, 4] . In addition, in a previous study, both rALP domains showed that the fungicidal activity was localized primarily in the NH 2 -terminal domain. As discussed we have shown that rALP may also inhibit exogenous proteases from microorganisms such as A. fumigatus, thereby partially by Hiemstra et al. [19] , this may be explained by a higher degree of cationicity of the NH 2 -terminal domain and by a protecting airway epithelial cells against cell detachment and inhibiting the production of proinflammatory cytokines by clustering of positively charged amino acid residues in the NH 2 -terminal domain. The antifungal activity of the individual these cells [32] . Second, protease inhibitors may display antibacterial activity toward gram-positive and -negative bacteria, rALP domains, either alone or in combination, was lower than that of the intact rALP molecule on a molar base. Conformaas has been described for aprotinin [6] and rALP [19] . A synthetic peptide mimicking the cysteine proteinase inhibitory site tional changes coinciding with diminished exposure of cationic sites in the individual domains may explain these differences. of human cystatin C was found to kill group A streptococci [7] , while eNAP-2, a cationic proteinase inhibitor purified from Alternatively, the COOH-terminal domain may contribute to the fungicidal activity of the NH 2 -terminal domain only in the equine neutrophils, killed various bacteria, including E. coli [18] . An anti -human immunodeficiency virus type 1 activity intact molecule. In addition to being fungicidal, rALP was fungistatic for for ALP was recently suggested by McNeely et al. [33] , although this was not confirmed by others [34] . With respect to C. albicans as well. Growth inhibition may contribute substantially to the mucosal host defense, since the ability to limit the the fungicidal activity of proteinase inhibitors, however, data are limited. Recent studies by Lorito et al. [35] have shown proliferation of fast-growing fungi such as C. albicans could limit their spread on mucocutaneous surfaces and may buy that proteinase inhibitors from plants can suppress spore germination and germ tube elongation of two species of phytopathotime for the cell-dependent and -independent host defense mechanisms to clear the fungus from the mucosa and host genic fungi, causing leakage of the intracellular contents from these plant pathogens.
tissues. Over recent years, interest in the discovery and development The mechanisms by which cationic proteins, especially defensins, kill microorganisms have been studied for many years.
of new antimicrobial agents has grown rapidly. The widespread use of immunosuppressive agents and the AIDS pandemic has Although the mechanisms involved are not yet fully understood, the bactericidal activity of defensins may be related to lead to a dramatic increase of mycoses [42 -46] . In addition, the treatment of mycoses with most of the antifungal drugs pore formation phenomena in the outer membrane of bacteria (reviewed in [36] ), resulting in loss of cell homeostasis. Comcurrently available is hampered by various adverse effects, including toxicity [47 -50] . Of major concern, however, is the parable mechanisms may also pertain to the fungicidal activity of cationic proteins such as ALP, and in fact, binding of cationic vast emerging resistance to antibiotic treatment of clinically important human pathogens, including fungi [51 -53] . Our reantimicrobial proteins, a prerequisite for pore formation, to the fungal cell wall chitin has been demonstrated [37] . An alternasults indicate that rALP has pronounced antifungal activity, although its activity is limited to conditions of low ionic tive mechanism for the fungicidal activity of bacteria has been suggested by studies with E. coli, showing the binding of ALP strength. Given its broad spectrum of antimicrobial activity, however, rALP may prove to be a promising agent in the to bacterial DNA and its interfering with bacterial RNases [38] , although such a mechanism alone probably does not explain prevention and treatment of microbial infections in humans. the observed antibacterial activity [19] .
